Lopez, Baby Boyy .
HRN: 23-15-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2023
CEFOTAXIME 500MG (VIAL)
06/15/2023
06/22/2023
IV
90mg
Q12hours
RDS Sec To Prematurity
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes